Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women
Genetic variance can influence breast cancer prognosis. Here, the authors conduct a meta-analysis to explore genetic variance linked to breast cancer in young women, identifying a prognostic association with germline variation of ADAMTSL1.
Guardado en:
Autores principales: | Latha Kadalayil, Sofia Khan, Heli Nevanlinna, Peter A. Fasching, Fergus J. Couch, John L. Hopper, Jianjun Liu, Tom Maishman, Lorraine Durcan, Sue Gerty, Carl Blomqvist, Brigitte Rack, Wolfgang Janni, Andrew Collins, Diana Eccles, William Tapper |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/845ca8f5900847e59759bac4ff1d722f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cooperative Mechanism of ADAMTS/ ADAMTSL and Fibrillin-1 in the Marfan Syndrome and Acromelic Dysplasias
por: Pauline Arnaud, et al.
Publicado: (2021) -
The extracellular matrix glycoprotein ADAMTSL2 is increased in heart failure and inhibits TGFβ signalling in cardiac fibroblasts
por: Karoline B. Rypdal, et al.
Publicado: (2021) -
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
por: Maria Escala-Garcia, et al.
Publicado: (2020) -
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
por: Maria Escala-Garcia, et al.
Publicado: (2021) -
Linkage of genetic drivers and strain-specific germline variants confound mouse cancer genome analyses
por: Sebastian Mueller, et al.
Publicado: (2020)